Label: DR. RECKEWEG R18 CYSTOPHYLIN COMBINATION PRODUCT- berberis vulgaris 4x, cantharis 4x, dulcamara 4x, equisetum hyemale 6x, eupatorium purpureum 3x liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved homeopathic

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Drug Label Information

Updated April 4, 2013

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Active ingredients

    Berberis vulgaris 4X, Cantharis 4X, Dulcamara 4X, Equisetum hyemale 6X, Eupatorium purpureum 3X, 1 g each in 10 g.

  • PURPOSE


    Purpose

    Relieves symptoms associated with bladder infection

  • INDICATIONS & USAGE


    Uses

    For the temporary relief of minor symptoms associated with bladder infection such as: 


    • Minor urinary discomfort
    • Pain and burning upon urination
    • Feeling of urinary urgency
  • WARNINGS

    Warnings

    Stop use and ask a doctor if symptoms persist, get worse, or if new symptoms occur.

    If pregnant or breastfeeding, ask a health care professional before use.

    Keep out of reach of children.

  • DOSAGE & ADMINISTRATION


    Directions

    Adults and children ≥ 12 years 5-10 drops 1-3 times daily, acute cases 4-6 times in a little water or undiluted or as recommended.

  • OTHER SAFETY INFORMATION

    Other information

    • Tamper resistant: do not use if safety ring at base of cap is broken.
    • Retain outer carton for full product information.
  • INACTIVE INGREDIENT

    Inactive ingredients

    Ethanol, purified water.

  • QUESTIONS


    Questions?

    Call 1-800-361-7872 or email questions@reckeweg.com

  • PRINCIPAL DISPLAY PANEL

    image of carton label

    NDC# 53346-1318-5

    Dr. Reckeweg R18 Cystophylin

    Homeopathic preparation for the temporary relief of minor symptoms associated with bladder infection such as:  

    • Minor urinary discomfort
    • Pain and burning upon urination
    • Feeling or urinary urgency

    Manufactured by:

    Dr. Reckeweg Co. GmbH

    D-64625 Bensheim

    Germany


    1.68 fl oz
    (50 ml)

  • INGREDIENTS AND APPEARANCE
    DR. RECKEWEG R18 CYSTOPHYLIN  COMBINATION PRODUCT
    berberis vulgaris 4x, cantharis 4x, dulcamara 4x, equisetum hyemale 6x, eupatorium purpureum 3x liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:53346-1318
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BERBERIS VULGARIS ROOT BARK (UNII: 1TH8Q20J0U) (BERBERIS VULGARIS ROOT BARK - UNII:1TH8Q20J0U) BERBERIS VULGARIS ROOT BARK4 [hp_X]  in 50 mL
    LYTTA VESICATORIA (UNII: 3Q034RO3BT) (LYTTA VESICATORIA - UNII:3Q034RO3BT) LYTTA VESICATORIA4 [hp_X]  in 50 mL
    SOLANUM DULCAMARA TOP (UNII: KPS1B1162N) (SOLANUM DULCAMARA TOP - UNII:KPS1B1162N) SOLANUM DULCAMARA TOP4 [hp_X]  in 50 mL
    EQUISETUM HYEMALE (UNII: 59677RXH25) (EQUISETUM HYEMALE - UNII:59677RXH25) EQUISETUM HYEMALE6 [hp_X]  in 50 mL
    EUTROCHIUM PURPUREUM ROOT (UNII: 0VYG5PVN5Q) (EUTROCHIUM PURPUREUM ROOT - UNII:0VYG5PVN5Q) EUTROCHIUM PURPUREUM ROOT3 [hp_X]  in 50 mL
    Inactive Ingredients
    Ingredient NameStrength
    ALCOHOL (UNII: 3K9958V90M)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:53346-1318-550 mL in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved homeopathic06/01/1986
    Labeler - PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO (318602612)
    Establishment
    NameAddressID/FEIBusiness Operations
    PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO318602612manufacture(53346-1318)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!